|
05.04.2016 20:10:00
|
Valeant Pharmaceuticals International, Inc -- Moody's: Conclusion of Valeant's Ad Hoc Committee a positive development
New York, April 05, 2016 -- Moody's Investors Service commented that the conclusion of the Ad Hoc Committee of Valeant Pharmaceuticals International, Inc. ("Valeant") with no additional adverse findings is a positive development. There are no changes to Valeant's ratings including the B2 Corporate Family Rating, the Caa1-PD Probability of Default Rating, the Ba2 senior secured rating or the B3 senior unsecured rating at this time. These ratings remain under review for downgrade.
Börse aktuell - Live Ticker
Asiens Börsen im MinusIn Asien verbuchen die Börsen am Donnerstag Verluste.
Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.